Please login to the form below

Not currently logged in
Email:
Password:

Acuitas Therapeutics

This page shows the latest Acuitas Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Pfizer expands access to lipid nanoparticle technology in new agreement with Acuitas Therapeutics

Pfizer expands access to lipid nanoparticle technology in new agreement with Acuitas Therapeutics

Pfizer has entered into a development and option agreement with Acuitas Therapeutics, a company focused on producing lipid nanoparticle (LNP) delivery systems to enable messenger RNA (mRNA)-based therapeutics. ... Speaking on behalf of Actuitas

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Genesis Research

Genesis Research is an international HEOR and RWE research organization. A leader in evidence strategy, generation and communication, the company...

Latest intelligence

Man vs microbe: the fight against antimicrobial resistance
How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics...
Is trust the key factor in digital HCP engagement? New whitepaper from Graphite Digital
Based on research with HCPs in the UK, USA and France, Graphite Digital’s latest whitepaper sheds light on HCP perceptions of pharma-owned digital channels, and what organisations should be prioritising...
HOW TO TRANSFORM YOUR HEALTHCARE BRAND MARKETING FROM MULTI-CHANNEL TO OMNICHANNEL
In a previous blog, we outlined the role of omnichannel in healthcare and the importance of personalised communications with the suggestion of using modular content to support an omnichannel approach....